Indu Dhariwal, HR Manager, Iberia PharmaceuticalsThe pharma industry is at a turning point, despite being the world’s third-largest producer of medicines by volume. The sector was once defined by process stability and regulatory discipline, however, now it is being driven by innovation and technology. This
The conference saw participation from more than 1900 individuals, with over 285 eminent speakers sharing their experiencesThe Indian Society for Clinical Research (ISCR), an association of clinical research professionals, successfully hosted its 19th Annual Conference bringing together more than 1900 individuals and 285 eminent speakers to explore how digital
The latest disbursement underscores the Company’s role in strengthening India’s domestic pharmaceutical manufacturing ecosystemVenus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the world’s leading fixed-dosage injectable manufacturers, has received its second incentive disbursement under the Government of India’s Production Linked Incentive (PLI) Scheme for Pharmaceuticals, representing 75 percent
The Delhi High Court has refused to grant interim protection to pharmaceutical company Alkem Laboratories Ltd. in its trademark dispute against Prevego Healthcare & Research Pvt Ltd, allowing the latter to continue selling its multivitamin product under the brand name Multivein AZ while the litigation
Senior leaders, policymakers, and experts discuss innovation, collaboration, and the future of life sciences R&D in India Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful day-long symposium brought together eminent voices, leaders, and experts from across India’s life sciences
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning discovery (chemistry, biology, drug
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combinationVenus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the world’s leading fixed-dosage injectable manufacturers, has secured the marketing authorization from the Indonesian regulatory authority
India’s Central Drugs Standard Control Organisation (CDSCO) has released new guidelines that allow the compounding of minor drug-related violations, marking a significant step toward faster enforcement, improved compliance, and reduced litigation within the pharmaceutical ecosystem.The guidelines outline specific categories of procedural and technical lapses that
Granules India Limited today inaugurated two advanced Centres of Excellence at the Technology Research Park of IIT Hyderabad: the Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering.The inauguration was led by Dr Krishna Prasad Chigurupati,
PNEUBEVAX 14® is Biological E. Limited’s 14-valent Pneumococcal Conjugate Vaccine· PNEUBEVAX 14® induces robust, functional serotype-specific immune response in infants to 14 serotypes, offering the broadest coverage of any paediatric Pneumococcal Conjugate Vaccine available in India Biological E. Limited (BE), a leading Hyderabad-based vaccine and pharmaceutical
